Steeghs, N., Gelderblom, H., Wessels, J., Eskens, F. A. L. M., de Bont, N., Nortier, J. W. R., & Guchelaar, H. (2009). Pharmacogenetics of telatinib, a VEGFR-2 and VEGFR-3 tyrosine kinase inhibitor, used in patients with solid tumors. Springer US.
Citação norma ChicagoSteeghs, Neeltje, Hans Gelderblom, Judith Wessels, Ferry A. L. M. Eskens, Natasja de Bont, Johan W. R. Nortier, and Henk-Jan Guchelaar. Pharmacogenetics of Telatinib, a VEGFR-2 and VEGFR-3 Tyrosine Kinase Inhibitor, Used in Patients With Solid Tumors. Springer US, 2009.
Citação norma MLASteeghs, Neeltje, et al. Pharmacogenetics of Telatinib, a VEGFR-2 and VEGFR-3 Tyrosine Kinase Inhibitor, Used in Patients With Solid Tumors. Springer US, 2009.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.